ClinicalTrials.Veeva

Menu

An In-vitro Real-time System Based on Tissue Smears to Identify Malignancy During Hysteroscopic Procedure

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Uterine Neoplasms
Uterine Cervical Neoplasm

Treatments

Procedure: Hysteroscopy
Device: Infrared Spectroscopy

Study type

Interventional

Funder types

Other

Identifiers

NCT03971032
HYMC-0098-18

Details and patient eligibility

About

The aim of the current study is to develop a near real-time system using infrared spectroscopy, that will evaluate the histological specimen that was removed from the uterine cavity during the hysteroscopy.

Enrollment

300 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing hysteroscopy

Exclusion criteria

  • Pregnancy

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

300 participants in 1 patient group

Women undergoing hysteroscopy
Other group
Description:
Women presenting with abnormal bleeding, abnormal cervical or uterine findings who have consented to undergo hysteroscopy
Treatment:
Procedure: Hysteroscopy
Device: Infrared Spectroscopy

Trial contacts and locations

1

Loading...

Central trial contact

Ilan Bruchim, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems